These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3669751)

  • 1. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT; Mold NG
    Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro".
    Fattorossi A; Dolei A; Pizzolo JG; Cafolla A; Mandelli F; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(2):87-92. PubMed ID: 3504087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A; Berman E; Black P; Koziner B
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S; Gamliel H; Golomb HM
    Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
    J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
    Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
    Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-induced surface alterations in hairy cells. A review.
    Gamliel H; Gurfel D; Wu SH; Golomb HM
    Scanning Microsc; 1988 Mar; 2(1):485-92. PubMed ID: 3368772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
    Wagner L; Goldstone AH; Worman CP
    Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features.
    Paoletti M; Bitter MA; Vardiman JW
    Clin Lab Med; 1988 Mar; 8(1):179-95. PubMed ID: 3282758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
    Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
    Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
    Pangalis GA; Kittas C; Viniou N; Kokkinou S; Variamis H; Paizis P; Melanthiou F; Fessas P
    Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.